Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT03276832
What this trial is testing

Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma

Who this might be right for
Metastatic MelanomaStage IIIB Cutaneous Melanoma AJCC v7Stage IIIC Cutaneous Melanoma AJCC v7+1 more
Mayo Clinic 7
Early research (Phase 1)Ended earlyNCT04967196
What this trial is testing

Ipilimumab and Nivolumab for the Treatment of Stage III-IV Unresectable Metastatic Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+1 more
Mayo Clinic 6
Testing effectiveness (Phase 2)Ended earlyNCT00509496
What this trial is testing

Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered Lymphocytes

Who this might be right for
Skin CancerMelanoma
National Cancer Institute (NCI) 21
Not applicableStudy completedNCT01209299
What this trial is testing

Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate

Who this might be right for
Melanoma (Skin)
ECOG-ACRIN Cancer Research Group 80
Testing effectiveness (Phase 2)Study completedNCT01253564
What this trial is testing

RO5185426 in Previously Treated Melanoma Patients With Brain Metastases

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 24
Testing effectiveness (Phase 2)Study completedNCT00005875
What this trial is testing

Nitrocamptothecin in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT01120275
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma

Who this might be right for
Acral Lentiginous Malignant MelanomaLentigo Maligna Malignant MelanomaNodular Malignant Melanoma+4 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)UnknownNCT00002817
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 30
Testing effectiveness (Phase 2)UnknownNCT04248387
What this trial is testing

Toripalimab in the Neoadjuvant Treatment of BRAF V600 Wild Type Melanoma

Who this might be right for
Melanoma Stage IIIB-IV
Fudan University 100
Testing effectiveness (Phase 2)Study completedNCT00089206
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Virginia 7
Very early researchNot Yet RecruitingNCT07700121
What this trial is testing

PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma

Who this might be right for
Unresectable or Metastatic Melanoma
Abramson Cancer Center at Penn Medicine 10
Testing effectiveness (Phase 2)UnknownNCT00002845
What this trial is testing

Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Blumenthal Cancer Center at Carolinas Medical Center 20
Early research (Phase 1)Study completedNCT00438984
What this trial is testing

Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 11
Testing effectiveness (Phase 2)Ended earlyNCT00082875
What this trial is testing

Cilengitide in Treating Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Stage III MelanomaStage IV Melanoma
National Cancer Institute (NCI) 56
Early research (Phase 1)Study completedNCT05303493
What this trial is testing

Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma

Who this might be right for
NSCLC Stage IVMelanoma Stage IVUnresectable Melanoma+1 more
Centre hospitalier de l'Université de Montréal (CHUM) 45
Testing effectiveness (Phase 2)Ended earlyNCT01551693
What this trial is testing

STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
Dana-Farber Cancer Institute 3
Not applicableStudy completedNCT00828126
What this trial is testing

PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 38
Large-scale testing (Phase 3)Study completedNCT00324727
What this trial is testing

Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)Metastatic Cancer
Delcath Systems Inc. 93
Post-approval studies (Phase 4)Ended earlyNCT01683188
What this trial is testing

HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Clinigen, Inc. 53
Testing effectiveness (Phase 2)Ended earlyNCT00087373
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 28
Next Page